Capital Flow Monitor · Sponsors · CIK 1782107
Onconetix, Inc.
201 E. FIFTH STREET, CINCINNATI, OH, 45202 · 513-620-4101
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$13.0M
Sold
$13.0M
% sold
100.0%
Investors
11
Min investment
$209K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-07 | D ·current | 506(b) | $13.0M | $13.0M | 100.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Karina Fedasz — Executive Officer, Cincinnati, OH
1 other raise
- HOPE-Neuron Therapeutx, Inc. $150K of $150K · 100.0%
- Simon Tarsh — Director, Cincinnati, OH
- Timothy Ramdeen — Director, Cincinnati, OH
- Thomas Meier — Director, Cincinnati, OH
- Andrew Oakley — Director, Cincinnati, OH
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.